Liam Ratcliffe, Director at Unum Therapeutics Inc. (UMRX), bought 897,773 shares at $12.00 ($3.3M) on 2018-04-03, disclosed to the SEC on 2018-04-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 622,773 | $0 | 0.0% |
| 2 | $12.00 | 275,000 | $3.3M | 100.0% |
| Total | $3.68 avg | 897,773 | $3.3M | 100% |
| Filing → |
| ARVN | SELL | 2021-11-09 | $30.9M | — | Filing → |
| ARVN | BUY | 2020-12-21 | $10.0M | — | Filing → |
| PASG | BUY | 2020-03-13 | $9.9M | — | Filing → |